OVID THERAPEUTICS INC (OVID) Stock Analyst Ratings
NASDAQ:OVID • US6904691010
1.42 USD
-0.08 (-5.33%)
At close: Feb 13, 2026
1.45 USD
+0.03 (+2.11%)
After Hours: 2/13/2026, 8:00:02 PM
ChartMill assigns a Buy % Consensus number of 88% to OVID. The Buy consensus is the weighted average rating of the current analysts ratings.
- Analysts have set a mean price target forecast of 4.26. This target is 199.89% above the current price.
- OVID was analyzed by 16 analysts. The buy percentage consensus is at 88. So analysts seem to be very confident about OVID.
- In the previous month the buy percentage consensus was at a similar level.
- OVID was analyzed by 16 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-12-22 | LifeSci Capital | Initiate | Outperform |
| 2025-12-22 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-12-11 | Roth Capital | Initiate | Buy |
| 2025-11-24 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-11-17 | Leerink Partners | Initiate | Outperform |
| 2025-05-27 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-03-24 | BTIG | Maintains | Buy -> Buy |
| 2025-03-12 | Wedbush | Maintains | Outperform -> Outperform |
| 2025-01-29 | Oppenheimer | Upgrade | Perform -> Outperform |
| 2024-12-04 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-09-30 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-19 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-07-26 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-07-02 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-06-18 | BTIG | Maintains | Buy -> Buy |
| 2024-06-18 | B. Riley Securities | Maintains | Buy -> Buy |
| 2024-06-18 | Citigroup | Maintains | Neutral -> Neutral |
| 2024-06-18 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-05-16 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-07 | Citigroup | Maintains | Neutral -> Neutral |
| 2024-04-30 | B. Riley Securities | Initiate | Buy |
| 2024-04-29 | HC Wainwright & Co. | Initiate | Buy |
| 2024-04-05 | Wedbush | Initiate | Outperform |
| 2023-12-21 | BTIG | Initiate | Buy |
| 2023-06-14 | JonesTrading | Initiate | Buy |
| 2023-05-02 | Ladenburg Thalmann | Reiterate | Buy |
| 2022-08-29 | Citigroup | Maintains | Neutral |
| 2022-05-20 | Citigroup | Maintains | Neutral |
| 2021-08-25 | Citigroup | Maintains | Neutral |
| 2021-04-20 | Cantor Fitzgerald | Downgrade | Overweight -> Neutral |
OVID THERAPEUTICS INC / OVID FAQ
What do analysts expect the price target to be for OVID THERAPEUTICS INC (OVID)?
16 analysts have analysed OVID and the average price target is 4.26 USD. This implies a price increase of 199.89% is expected in the next year compared to the current price of 1.42.
What is the consensus rating for OVID THERAPEUTICS INC (OVID) stock?
The consensus rating for OVID THERAPEUTICS INC (OVID) is 87.5 / 100 . This indicates that analysts generally have a positive outlook on the stock.